OPGN Opgen Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPGN

Price (delayed)

$0.48

Market cap

$4.81M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.51

Enterprise value

$17.07M

OpGen, Inc. (Gaithersburg, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with subsidiaries, Curetis GmbH and Ares ...

Highlights
The company's gross margin has surged by 150% YoY and by 115% QoQ
Opgen's gross profit has surged by 147% YoY and by 116% QoQ
OPGN's revenue is up by 9% since the previous quarter but it is down by 7% year-on-year
The company's quick ratio has shrunk by 93% YoY and by 81% QoQ
OPGN's equity has dropped by 81% year-on-year and by 61% since the previous quarter
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opgen.com
Peers: STEM ENZ RDUS ADMA

Key stats

What are the main financial stats of OPGN
Market
Shares outstanding
10.01M
Market cap
$4.81M
Enterprise value
$17.07M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.6
Price to sales (P/S)
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.56
Earnings
Revenue
$3.07M
EBIT
-$23.83M
EBITDA
-$22.42M
Free cash flow
-$17.84M
Per share
EPS
-$6.51
Free cash flow per share
-$2.03
Book value per share
$0.3
Revenue per share
$0.35
TBVPS
$1.29
Balance sheet
Total assets
$18.13M
Total liabilities
$15.46M
Debt
$12.55M
Equity
$2.68M
Working capital
-$9.02M
Liquidity
Debt to equity
4.69
Current ratio
0.28
Quick ratio
0.06
Net debt/EBITDA
-0.55
Margins
EBITDA margin
-730.2%
Gross margin
6.6%
Net margin
-852.1%
Operating margin
-772.8%
Efficiency
Return on assets
-112.7%
Return on equity
-398.1%
Return on invested capital
-170.5%
Return on capital employed
-420.7%
Return on sales
-776%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OPGN stock price

How has the Opgen stock price performed over time
Intraday
17.07%
1 week
-9.43%
1 month
-22.71%
1 year
-29.62%
YTD
14.29%
QTD
-30.94%

Financial performance

How have Opgen's revenue and profit performed over time
Revenue
$3.07M
Gross profit
$203,121
Operating income
-$23.73M
Net income
-$26.16M
Gross margin
6.6%
Net margin
-852.1%
The company's gross margin has surged by 150% YoY and by 115% QoQ
Opgen's gross profit has surged by 147% YoY and by 116% QoQ
OPGN's operating margin is up by 35% since the previous quarter and by 16% year-on-year
OPGN's net margin is up by 34% since the previous quarter and by 16% year-on-year

Growth

What is Opgen's growth rate over time

Valuation

What is Opgen stock price valuation
P/E
N/A
P/B
1.6
P/S
1.37
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
5.56
OPGN's EPS has soared by 65% YoY and by 46% QoQ
OPGN's equity has dropped by 81% year-on-year and by 61% since the previous quarter
OPGN's P/B is 61% above its last 4 quarters average of 1.0 but 5% below its 5-year quarterly average of 1.7
The price to sales (P/S) is 82% lower than the 5-year quarterly average of 7.7 and 27% lower than the last 4 quarters average of 1.9
OPGN's revenue is up by 9% since the previous quarter but it is down by 7% year-on-year

Efficiency

How efficient is Opgen business performance
Opgen's ROE has plunged by 185% YoY and by 3.2% from the previous quarter
Opgen's ROA has plunged by 51% YoY but it has increased by 16% from the previous quarter
OPGN's ROS is up by 35% QoQ and by 13% YoY
The return on invested capital has grown by 25% since the previous quarter and by 2.5% year-on-year

Dividends

What is OPGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPGN.

Financial health

How did Opgen financials performed over time
The company's total assets is 17% higher than its total liabilities
The company's quick ratio has shrunk by 93% YoY and by 81% QoQ
OPGN's current ratio has dropped by 75% year-on-year and by 52% since the previous quarter
The company's debt to equity has surged by 154% QoQ
OPGN's equity has dropped by 81% year-on-year and by 61% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.